ESCRS 2023: Integrated workflow solutions in cataract procedures

News
Video

Euan Thomson, the President of Ophthalmic Devices, Carl Zeiss Meditec spoke with our team about integrated workflow solutions and how they can benefit cataract procedures while at the 2023 ESCRS meeting in Vienna, Austria.

Euan Thomson, the President of Ophthalmic Devices, Carl Zeiss Meditec spoke with our team about integrated workflow solutions and how they can benefit cataract procedures while at the 2023 ESCRS meeting in Vienna, Austria.

Video Transcript

Editor's note - This transcript has been edited for clarity.

Euan Thomson: So I'm Euan Thompson, I'm President of Ophthalmology at Carl Zeiss, and Head of Digital Business. You know, we're working very hard on creating integrated workflow solutions. This is a big theme for us. And I think that, as people go around our booth, there's actually going to be a high level of integration that we've already been able to achieve.

Some of our workflows are complete; cataract workflow, for example, is there. And we've actually been able to demonstrate the value of this to customers. So we're really targeting new value propositions beyond the technology itself. We're really looking at efficiency gains in the operating room efficiency gains in the run up to a treatment. We're looking at quality improvement, standardization, and we're actually already gathering data on these. So we're really excited about that and really looking forward to showcasing it today.

So what I'm looking forward to in 2024, is really, really demonstrating the power of the level of integration that we've achieved, you know, our digitally connected workflows are really quite evolved now. The true value of those in terms of, you know, the efficiency gains and standardization and so on these new value propositions, being able to test those and getting the data back is really exciting, you know. A cataract workflow, we've actually now got demonstrable data that shows that there is a true efficiency gain, not just in the run up to a treatment but in the operating room itself. And it can be as high as 30% timesaving in the operating room for some procedures. So this is meaningful improvements in the standard of care.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.